Tech Company Financing Transactions
Immune Design Funding Round
Immune Design, operating out of Seattle, secured $10.6 million in investment from Alta Partners, ProQuest Investments and private investors.
Transaction Overview
Company Name
Announced On
12/31/2012
Transaction Type
Venture Equity
Amount
$10,625,000
Round
Undisclosed
Investors
Alta Partners (Ed Penhoet)
ProQuest Investments (Alain Schreiber)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1616 Eastlake Ave. East 310
Seattle, WA 98102
USA
Seattle, WA 98102
USA
Phone
Website
Email Address
Overview
Immune Design is a breakthrough therapeutic vaccine product development company utilizing two proprietary and integrated platform technologies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Carlos Paya
Chief Medical Officer
Sergey Yurasov
Chief Scientific Officer
Jan Meulen
Vice President
Frank Hsu
Vice President
Sandy Mohan
Vice President
Melanie Morrison
VP - Bus. Development
Wayne Gombotz
VP - Finance
Stephen Brady
VP - Regulatory Affairs
Heidi Petersen
Browse more venture capital transactions:
Prev: 12/31/2012: Kapow venture capital transaction
Next: 12/31/2012: CrestaTech venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on all VC transactions involving tech companies. VC investment data records on this site are sourced from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs